Fisher & Paykel Healthcare Corporation Limited has provided a copy of the Notice of Meeting for its 2022 Annual Shareholders’ Meeting, which will be held at the Guineas Room, Ellerslie Event Centre, Auckland, New Zealand on Wednesday, 24 August at 2.00pm (NZST) and online at www.virtualmeeting.co.nz/FPH22.
The attached Notice of Meeting and Voting Form will be mailed to shareholders who have not provided the company’s share registrar with an email address. An electronic copy of these documents will also be available on the company’s website at https://www.fphcare.co.nz/asm.
About Fisher & Paykel Healthcare
Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
GM Corporate Communications
+64 (0) 21 713 911
Investor Relations Manager
+64 (0) 27 807 8073
2022 Notice of Annual Meeting and Voting Form
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment